Amwell® to participate in upcoming investor conferences
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:
- Wells Fargo 21st Annual Healthcare Conference, on Wednesday, September 9, 2026, in Boston, MA. Mark Hirschhorn, CFO and COO, will represent the Company.
- Morgan Stanley 24th Annual Global Healthcare Conference, on Wednesday, September 16, 2026, along with an in-person fireside chat from 1:05 p.m. to 1:40 p.m. ET, in New York, NY. Mark Hirschhorn, CFO and COO, will represent the Company.
Details regarding audio webcasts, where available, will be posted on the Company's investor relations website at https://investors.amwell.com.
About Amwell
Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalized, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Media Contact
Press inquiries:
press@amwell.com
Investor contact:
Asher Dewhurst
amwell@icrhealthcare.com
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
What’s Ahead for Stocks This Quarter—and Where to Invest
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
United States